PK modeling in BE [NCA / SHAM]

posted by mittyri – Russia, 2020-07-19 02:24 (1607 d 10:04 ago) – Posting: # 21744
Views: 5,290

Hi Helmut,

❝ However, last year at the 10th American Conference on Pharmacometrics (20–23 October, Orlando) she gave a presentation “Evaluation of Model Based BioEquivalence (MBBE) statistical approaches for sparse designs PK studies” with a whoopy mean (!) Type I Error of 7.6%. :-(


Are you referring to this one?
Stan approach is a bit better, but still questionable

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,336 posts in 4,902 threads, 1,666 registered users;
39 visitors (0 registered, 39 guests [including 8 identified bots]).
Forum time: 11:29 CET (Europe/Vienna)

Biostatistician. One who has neither the intellect for mathematics
nor the commitment for medicine but likes to dabble in both.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5